Relmada Therapeutics Company Profile (OTC:RLMDD)

About Relmada Therapeutics (OTC:RLMDD)

Relmada Therapeutics logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTC:RLMDD
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: $56.64 million
  • Outstanding Shares: 11,999,000
Average Prices:
  • 50 Day Moving Avg: $3.11
  • 200 Day Moving Avg: $5.64
  • 52 Week Range: $11,999,000.00 - $2.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.24
  • P/E Growth: 0.00
 

Frequently Asked Questions for Relmada Therapeutics (OTC:RLMDD)

What is Relmada Therapeutics' stock symbol?

Relmada Therapeutics trades on the OTC under the ticker symbol "RLMDD."

Who are some of Relmada Therapeutics' key competitors?

Some companies that are related to Relmada Therapeutics include Alco Stores (ALCSQ), Cal Dive International (CDVI) and Liberty Media Co. - Series A Liberty Formula One (FWONA).

How do I buy Relmada Therapeutics stock?

Shares of Relmada Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Relmada Therapeutics stock cost?

One share of Relmada Therapeutics stock can currently be purchased for approximately $4.72.

Analyst Ratings

Consensus Ratings for Relmada Therapeutics (OTC:RLMDD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Relmada Therapeutics (OTC:RLMDD)
Show:
DateFirmActionRatingPrice TargetDetails
9/3/2015FBR & CoInitiated CoverageMarket Perform$7.00View Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for Relmada Therapeutics (OTC:RLMDD)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Relmada Therapeutics (OTC:RLMDD)
2017 EPS Consensus Estimate: ($0.70)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.16)($0.16)($0.16)
Q2 20171($0.18)($0.18)($0.18)
Q3 20171($0.18)($0.18)($0.18)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Relmada Therapeutics (OTC:RLMDD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Relmada Therapeutics (OTC:RLMDD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Relmada Therapeutics (OTC:RLMDD)
Latest Headlines for Relmada Therapeutics (OTC:RLMDD)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

This page was last updated on 5/26/2017 by MarketBeat.com Staff